Bipolar Depression clinical trials

Explore recruiting bipolar depression clinical trials.

Recruiting bipolar depression studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Bipolar Depression trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A study to evaluate the effect of multiple doses of carbamazepine and itraconazole on how long JNJ-55308942 stays in the body (pharmacokinetics) in healthy adults.

Belgium

Human Pharmacology (Phase I)- Other EU CTIS Study details

OSU6162 in Bipolar Depression: An Open-label, Flexible Dose Study (OBID)

Sweden

Therapeutic exploratory (Phase II) EU CTIS Study details

A randomised, controlled trial to investigate the effect of a six-week intensified pharmacological treatment for bipolar depression compared to treatment as usual in subjects who had a first-time treatment failure on their first-line treatment.

Italy, Spain, Germany, Austria, Greece

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 3, Randomized, Double-blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Azetukalner in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)

Germany, Bulgaria, Spain, Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Multicenter, Long-term, Open-Label, Safety, Tolerability, and Efficacy Study of Azetukalner in Bipolar I or II Depression

Bulgaria, Germany, France, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Lithium versus cariprazine in the acute phase treatment of bipolar depression: a pragmatic head-to-head open, randomized multicenter study. The 9th study of the Danish University Antidepressant Group (DUAG 9)

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

Bipolar Depression trials by city

Bipolar Depression in Toronto Bipolar Depression in Vancouver Bipolar Depression in Montreal Bipolar Depression in Calgary Bipolar Depression in Edmonton Bipolar Depression in Ottawa Bipolar Depression in Winnipeg Bipolar Depression in Quebec City Bipolar Depression in Hamilton Bipolar Depression in Kitchener Bipolar Depression in London Bipolar Depression in Halifax Bipolar Depression in New York Bipolar Depression in Los Angeles Bipolar Depression in Chicago Bipolar Depression in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease